Formulated to Enhance Bone Fusion

• Viable spine-derived cells are collected from the vertebral body region of the donor and preserved with the use of a next generation DMSO-free cryoprotectant
• A demineralized bone scaffold with osteoinductive potential which provides exposure of signaling molecules and bone morphogenetic proteins¹

DMSO-Free without compromise

• ≥150,000 cells / cc for osteogenic supplementation²
• Proprietary DMSO-free cryoprotectant that requires no rinsing or decanting steps required
• OR ease of use with no rinsing or decanting steps required
• 4-hour working window for implantation

Evidenced-Based Application: Fusion

• MIS-TLIF study demonstrated 96% fusion at 12 months³
• MIS-LLIF study demonstrated 94% fusion at 12 months⁴

1. Gruskin, E. et.al., Demineralized bone matrix in bone repair: history and use. Advanced Drug Delivery Reviews, 2012. 64:1063-1077. ​

2. Data on file at VIVEX Biologics, Inc. ​

3. Tally, William C, et al., Transforaminal Lumbar Interbody Fusion with Viable Allograft: 75 Consecutive Cases at 12-Month Follow-Up. Int J Spine Surg, 2018. Vol. 12, No. 1 p. 76-84.​

4. Talley WC, Temple HT, Burkus JK Lateral lumbar intebody fusion using a cellular allogenic bone matrix in the treatment of symptomatic degenerative lumbar disc disease and lumbar spinal instability. Int J Spine Surg. 2021; 7(3):310-317​